Psychedelic ResearchPsychedelics NewsThe 5 Most Important Psychedelics Innovations of the Last 10 YearsJanuary 5, 2021
Psychedelic EducationPsychedelic Medicine7 Things You Need to Know About Psychedelic MedicineDecember 29, 2020
Psychedelic MedicineNovamind CEO Shares His Thoughts on Psychedelics, Policy, and HealingDecember 19, 2020
Psychedelic EducationHow Can Industry Leaders Help Advance Psychedelics Policy Forward?December 11, 2020
Psychedelic FinanceAll Psychedelics Entrepreneurs Should Ask Themselves These Three QuestionsNovember 30, 2020
Psychedelic Medicine“Lots of us really want to see something very different happen with psychedelics.” Clark Howell’s founding law partners weigh in with an alternative vision of the psychedelics space.November 15, 2020
Psychedelic TherapyNikolai Vassev, CEO of Mindleap Health Inc., Talks Shop with Segev LLPNovember 3, 2020
Psychedelic MedicineA Chief Psychedelic Officer Shares His Thoughts on Mushroom Purity, Canadian Regulation, and MoreNovember 3, 2020
Psychedelic FinanceThoughts from an Industry Veteran on Legitimizing Psychedelics through Fiscal NormalizationNovember 1, 2020
Psychedelic MedicineJeff Stevens, CEO of Psyched Wellness, Discusses the Psychedelics Scene and His Company’s Fresh Take on Psilocybin TreatmentOctober 29, 2020
Psychedelic EducationA Discussion on Cannabis, Psychedelics, and the Law, with Ron Segev of Segev LLPOctober 27, 2020
Psychedelic MedicineDr. Evan Wood of Numinus Discusses Cultural Baggage, Regulation, and Psychedelic-Assisted TherapiesOctober 25, 2020
Psychedelic Therapy“The belief that the patient is in possession of all their own answers is one I stand by,” Says Timothy Ko on Psychedelics for Addiction TreatmentOctober 18, 2020
